Search

Your search keyword '"Calvo, Virginia"' showing total 332 results

Search Constraints

Start Over You searched for: Author "Calvo, Virginia" Remove constraint Author: "Calvo, Virginia"
332 results on '"Calvo, Virginia"'

Search Results

4. Machine Learning-Assisted Recurrence Prediction for Early-Stage Non-Small-Cell Lung Cancer Patients

6. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

9. Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk

10. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

12. Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

14. Immunogenicity of COVID-19 vaccines in lung cancer patients

15. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

16. IASIS and BigMedilytics: Towards personalized medicine in Europe

17. Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

18. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

19. Children with Autism and Picture Books: Extending the Reading Experiences of Autistic Learners of Primary Age

20. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

21. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

22. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation

23. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7

24. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

25. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)

26. Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

29. Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

30. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

32. Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC

34. Machine Learning Survival Models for Relapse Prediction in a Early Stage Lung Cancer Patient

35. DetectingALK,ROS1andRETfusions and theMETΔex14splicing variant in liquid biopsies of non‐small cell lung cancer patients using RNA ‐based techniques

36. Data from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

37. Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

38. Supplementary Data 1 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

39. Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population

40. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden

42. Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors

43. Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

47. Prognostic value of event‐free survival at 12 and 24 months and long‐term mortality for non‐Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

48. Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques.

49. Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer.

50. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

Catalog

Books, media, physical & digital resources